Encéphalopathie hépatique secondaire àla prise de flu t a mi de pour cancer de la prostate

Translated title of the contribution: Hepatic encephalopathy secondary to administra-tion of flutamide for prostate cancer

H. Patel, E. Rhee, P. H E Zimmern

Research output: Contribution to journalArticle

3 Scopus citations

Abstract

A 72-year-old male treated with flutamide for metastatic prostate cancer developed lethargy and confusion. He was noted to be icteric and his liver enzymes were elevated. Within a week of dicontinuing the medication, the patient's mental status and liver function returned to normal. Although flutamide-induced near fatal liver dysfunction has been described, progression to encephalopathy is a rare occurrence. Based on a review of the literature, management guidelines for the use of flutamide are suggested.

Translated title of the contributionHepatic encephalopathy secondary to administra-tion of flutamide for prostate cancer
Original languageFrench
Pages (from-to)123-125
Number of pages3
JournalJournal d'urologie
Volume102
Issue number3
StatePublished - Dec 1 1996

Keywords

  • Flutamide
  • Hepatic encephalopathy
  • Prostate cancer

ASJC Scopus subject areas

  • Urology

Fingerprint Dive into the research topics of 'Hepatic encephalopathy secondary to administra-tion of flutamide for prostate cancer'. Together they form a unique fingerprint.

  • Cite this